DiscGenics
Blood & Organ Banks · Utah, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5940 W Harold Gatty Dr, Salt Lake City, ...Phone Number
(801) 410-0703Website
www.discgenics.comRevenue
$6.2 MillionIndustry
About DiscGenics
DiscGenics is dedicated to developing innovative regenerative therapies aimed at alleviating pain and restoring function for patients suffering from degenerative diseases of the spine. Their primary product candidate, IDCT, is an allogeneic, injectable cell therapy designed to treat mild to moderate lumbar disc degeneration. The company focuses on engineering specialized therapeutic progenitor cells, known as Discogenic Cells, to address the complexities of degenerated discs. DiscGenics aims to revolutionize the treatment of chronic back pain for millions of patients.Explore more
DiscGenics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to DiscGenics
Compare insights from companies similar to DiscGenics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
DiscGenics
$6.2M
11-50
Private
$71.9M
2007
RW
Robert WynalekChief Operating Officer & Chief Commercialization Officer
DiscGenics Tech Stack
A closer look at the technologies used by DiscGenics
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DiscGenics
Sign Up For FreeTo access detailed company insights
DiscGenics is dedicated to developing innovative regenerative therapies aimed at alleviating pain and restoring function for patients suffering from degenerative diseases of the spine. Their primary product candidate, IDCT, is an allogeneic, injectable cell therapy designed to treat mild to moderate lumbar disc degeneration. The company focuses on... Read More
